# The Effect of Intranasal Oxytocin on Emphatic Abilities in Patients With Post Traumatic Stress Disorder (PTSD)

> **NCT01325168** · PHASE4 · COMPLETED · sponsor: **Rambam Health Care Campus** · enrollment: 62 (actual)

## Conditions studied

- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** syntocinon nasal spray
- **DRUG:** placebo nasal spray

## Key facts

- **NCT ID:** NCT01325168
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-08
- **Final completion:** 2013-04
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2015-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01325168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01325168, "The Effect of Intranasal Oxytocin on Emphatic Abilities in Patients With Post Traumatic Stress Disorder (PTSD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01325168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*